AGENDA

返回
搜索
11月24日
SAHZU-Harvard International Medical Innovation Forum
观看回放
19:30–22:05
Moderators
Albert Hofman
Chair,DepartmentofEpidemiology,HarvardT.H.ChanSchoolofPublicHealth
19:30–19:35
Opening Remarks
Wang Jian'an
TheSecondAffiliatedHospitalZhejiangUniversitySchoolofMedicine Chairman
19:35–20:00
Randomized Trials of Inflammation Inhibition for Atherosclerotic Disease: Moving From Theory to Practice
Paul M Ridker
Director,CenterforCardiovascularDiseasePrevention,BrighamandWomen’sHospital
20:00–20:25
Experience on International Multi-center Clinical Trials
HU Xinyang
VicePresident,SAHZU,China
20:25–20:50
High-quality Clinical Research Fuels Research Hospital
XU Ruihua
PresidentandProfessor,SunYat-senUniversityCancerCenter,China
20:50–21:15
Target Trial Emulation: a framework to find what works when no randomized trials are available
Miguel Hernán
Director,CAUSALab,DepartmentofEpidemiology,HarvardT.H.ChanSchoolofPublicHealth
KolokotronesProfessorofBiostatisticsandEpidemiology,HarvardT.H.ChanSchoolofPublicHealth
21:15–21:40
Innovation for Value-Based Care
XIONG Lize
President,ShanghaiFourthPeople’sHospitalAffiliatedtoTongjiUniversity,China
21:40–22:05
Platform Clinical Trials, the What, Why and How: Example from ALS
Lori Chibnik
DepartmentofEpidemiology,HarvardTHChanSchoolofPublicHealthAssociate Professor
DepartmentofNeurology,HarvardMedicalSchoolAssociate Professor